Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment (Q38627721)

4 September 2017

title

Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment (English)

1 reference

4 September 2017

1 reference

Alex Kiselyov

1

1 reference

4 September 2017

Svetlana Bunimovich-Mendrazitsky

series ordinal

2

1 reference

4 September 2017

Vladimir Startsev

series ordinal

3

1 reference

4 September 2017

language of work or name

English

0 references

publication date

6 November 2015

1 reference

International Journal of Cancer

4 September 2017

published in

1 reference

4 September 2017

volume

138

1 reference

4 September 2017

issue

11

1 reference

4 September 2017

page(s)

2562-2569

1 reference

The molecular background of urothelial cancer: ready for action?

4 September 2017

cites work

1 reference

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

21 January 2018

1 reference

Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice

21 January 2018

1 reference

Comprehensive molecular characterization of urothelial bladder carcinoma

21 January 2018

1 reference

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

21 January 2018

1 reference

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy

21 January 2018

1 reference

Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer

21 January 2018

1 reference

A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors

21 January 2018

1 reference

Predictive markers in bladder cancer: do we have molecular markers ready for clinical use?

21 January 2018

1 reference

The combinatorial complexity of cancer precision medicine

21 January 2018

1 reference

Targeting the Hedgehog pathway in cancer

21 January 2018

1 reference

Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma

21 January 2018

1 reference

Hedgehog pathway activation in human transitional cell carcinoma of the bladder

21 January 2018

1 reference

p63 expression defines a lethal subset of muscle-invasive bladder cancers

21 January 2018

1 reference

A new tumor suppressor role for the Notch pathway in bladder cancer

21 January 2018

1 reference

The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.

21 January 2018

1 reference

Expression of OCT4A: the first step to the next stage of urothelial bladder cancer progression

21 January 2018

1 reference

Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer

21 January 2018

1 reference

Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder

21 January 2018

1 reference

Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling.

21 January 2018

1 reference

Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior

21 January 2018

1 reference

Significance of ERBB2 overexpression in therapeutic resistance and cancer-specific survival in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach.

21 January 2018

1 reference

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder

21 January 2018

1 reference

Constitutive β-catenin activation induces male-specific tumorigenesis in the bladder urothelium

21 January 2018

1 reference

ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.

21 January 2018

1 reference

Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder

21 January 2018

1 reference

Mammalian target of rapamycin complex 2 (mTORC2) is a critical determinant of bladder cancer invasion

21 January 2018

1 reference

Genome sequencing identifies a basis for everolimus sensitivity

21 January 2018

1 reference

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib

21 January 2018

1 reference

Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer

21 January 2018

1 reference

Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75

21 January 2018

1 reference

CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma.

21 January 2018

1 reference

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

21 January 2018

1 reference

Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease

21 January 2018

1 reference

Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression

21 January 2018

1 reference

Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer

21 January 2018

1 reference

Interleukin-20 promotes migration of bladder cancer cells through extracellular signal-regulated kinase (ERK)-mediated MMP-9 protein expression leading to nuclear factor (NF-κB) activation by inducing the up-regulation of p21(WAF1) protein expressio

21 January 2018

1 reference

TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis.

21 January 2018

1 reference

Human leukocyte antigen class I down-regulation in muscle-invasive bladder cancer: its association with clinical characteristics and survival after cystectomy

21 January 2018

1 reference

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential

21 January 2018

1 reference

Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer

21 January 2018

1 reference

Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome

21 January 2018

1 reference

Galectin-3 expression is associated with bladder cancer progression and clinical outcome

21 January 2018

1 reference

Association of hyaluronic acid family members (HAS1, HAS2, and HYAL‐1) with bladder cancer diagnosis and prognosis

21 January 2018

1 reference

Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis

21 January 2018

1 reference

Nuclear cIAP1 overexpression is a tumor stage- and grade-independent predictor of poor prognosis in human bladder cancer patients

21 January 2018

1 reference

Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer.

21 January 2018

1 reference

SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.

21 January 2018

1 reference

Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation

21 January 2018

1 reference

Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer

21 January 2018

1 reference

EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo

21 January 2018

1 reference

Epigenetic inactivation of ST6GAL1 in human bladder cancer

21 January 2018

1 reference

Methylation-mediated silencing of Dlg5 facilitates bladder cancer metastasis

21 January 2018

1 reference

Expression and function role of DNA methyltransferase 1 in human bladder cancer

21 January 2018

1 reference

Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.

21 January 2018

1 reference

Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression

21 January 2018

1 reference

Prediction of drug response in breast cancer using integrative experimental/computational modeling

21 January 2018

1 reference

Hybrid discrete-continuous model of invasive bladder cancer.

21 January 2018

1 reference

B domain containing Tenascin-C: A new urine marker for surveillance of patients with urothelial carcinoma of the urinary bladder?

21 January 2018

1 reference

Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29918

1 reference

release_kabnakxjkjbhdi6fimnzg6emru

4 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kabnakxjkjbhdi6fimnzg6emru

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference